DURHAM, N.C. (WTVD) -- Remdesivir, an antiviral drug that was developed right here in Triangle, is playing a key role in President Trump's path to recovery from COVID-19. Right now, doctors at UNC and ...

We know researchers are working hard to develop a vaccine for the coronavirus, but they are also working on treatments to fight the disease right now. And one experimental antiviral drug in that fight ...

The treatment drug remdesivir showed promise for moderately ill coronavirus patients in a recent trial, the drug’s maker says. Gilead Sciences, which makes remdesivir, released results of the trial ...

The virus that causes COVID-19 might be becoming resistant to antiviral treatments, new research has warned. But should we be concerned? The antiviral drugs nirmatrelvir and remdesivir are recommended ...

Remdesivir, an experimental antiviral drug from Gilead Sciences, has shown promise based on early results in people with severe COVID-19, the disease caused by the new coronavirus. But experts caution ...

Oct 22 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's (GILD.O), opens new tab antiviral drug remdesivir for treating patients hospitalized with COVID-19, ...

The preliminary results showed that hospitalized patients who received remdesivir recovered 31% faster. Dr. Anthony Fauci hailed the findings as... Preliminary results of a major study of the ...

The FDA has issued emergency-use authorization for a drug tested at UVA Health to be used against COVID-19. The antiviral drug, remdesivir, becomes the first treatment authorized to battle the ...

GENEVA — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the ...

President Donald Trump is receiving an experimental antiviral for Covid-19 called remdesivir as he remains hospitalized at Walter Reed National Military Medical Center in Bethesda, Maryland. The drug ...

Dec 11 (Reuters) - Europe's drugs regulator on Friday recommended changing some terms of the conditional approval given to antiviral drug remdesivir as a COVID-19 treatment, to make clear the ...

The Food and Drug Administration has approved the antiviral drug remdesivir, sold under the brand name Veklury, as a treatment for COVID-19, the disease caused by the novel coronavirus. After ...